Lifestyle
- Regular exercise
- Stress management
- Adequate hydration
Serum Transferrin · Siderophilin
Transferrin measures the level of the iron-binding glycoprotein responsible for iron transport in the blood.
Reference ranges may vary slightly based on laboratory standards and patient demographics.
Transferrin is a glycoprotein primarily responsible for the transport of iron throughout the bloodstream, binding to iron ions and facilitating their delivery to various tissues. It plays a crucial role in maintaining iron homeostasis and is synthesized mainly in the liver. Clinically, transferrin levels are significant in diagnosing and managing iron-related disorders. Elevated transferrin levels may indicate iron deficiency anemia, as the body increases transferrin production to maximize iron transport. Conversely, low transferrin levels can be associated with conditions such as chronic inflammation, liver disease, or protein malnutrition. In the context of athletic performance and biohacking, transferrin is relevant due to its role in oxygen transport and energy metabolism. Athletes may monitor transferrin to optimize iron levels for enhanced endurance and recovery. However, transferrin levels can be influenced by various factors, including nutritional status, inflammation, and liver function. It is important to consider these confounders when interpreting transferrin measurements, as well as the potential need for fasting or time-of-day considerations to ensure accurate results.
Klinische Bedeutung
Elevated transferrin levels typically indicate iron deficiency anemia, while reduced levels may suggest chronic disease, liver dysfunction, or protein malnutrition.
Progressively rising transferrin levels may suggest worsening iron deficiency. Re-test in 4 weeks if outside optimal range.
Falling transferrin levels could indicate resolving iron deficiency or onset of chronic disease.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a physician before starting iron supplementation, especially if underlying conditions are suspected.
Transferrin levels can vary with diurnal rhythms; morning samples are preferred.
Testing Frequency
Annually for healthy adults, more frequently if managing iron-related conditions.
May affect
Current research suggests that reference ranges for carbohydrate-deficient transferrin (CDT) are not standardized, leading to variability in clinical interpretations. Researchers have not yet established optimal targets for transferrin receptor measurements in distinguishing iron-deficiency anemia from other types of anemia. Additionally, unanswered clinical questions remain regarding the diagnostic accuracy of transferrin in congenital disorders of glycosylation and the implications of serum transferrin levels in various inflammatory conditions.
1,388
Total Citations
3
Human/RCT
4.6
Avg. Influence
2024
Latest
Researchers found that the transferrin receptor 1 protein (TfR1) can be used as a specific marker to identify cells undergoing ferroptosis, a regulated form of cell death. They developed a monoclonal antibody that selectively stains these cells, enhancing the ability to study ferroptosis in various contexts.
Researchers found that transferrin saturation (TSAT) is an important biomarker for assessing body iron status, linking it to health outcomes such as cardiovascular mortality. They cautioned about the limitations of TSAT measurements, particularly in inflammatory conditions.
This study examined the challenges in diagnosing congenital disorders of glycosylation (CDG), noting that serum transferrin isoelectrofocusing is only positive in about 60% of cases. Researchers provided practical tools to aid in the diagnosis of CDG, emphasizing the need for awareness of these disorders in unexplained syndromes.
Researchers observed that serum transferrin receptor levels are a useful indicator of iron deficiency and erythropoiesis. They highlighted its clinical utility in distinguishing between different types of anemia, particularly in identifying iron deficiency anemia. The study supports the routine use of this marker in evaluating anemic patients.
In a pilot study, researchers evaluated the effects of oral D-galactose supplementation in patients with PGM1-CDG. They observed significant improvements in transferrin-glycosylation and other laboratory parameters, suggesting potential benefits of this treatment.
Researchers reviewed various established and novel biomarkers for diagnosing iron deficiency, including transferrin and transferrin saturation. They discussed the limitations of current diagnostic tools and the need for improved methods to differentiate between types of anemia.
Researchers found that measuring serum transferrin receptor levels can reflect body iron stores and erythropoiesis. They noted that the serum transferrin receptor to ferritin ratio is useful for differentiating iron deficiency anemia from other types of anemia.
Researchers summarized the standardization efforts for carbohydrate-deficient transferrin (CDT) as a biomarker for alcohol consumption. They outlined the establishment of reference measurement procedures and the importance of uniformity in CDT measurement for clinical applications.
This review examined iron deficiency anemia (IDA), highlighting its prevalence and laboratory diagnosis. Researchers found that IDA is characterized by low serum iron, decreased transferrin saturation, and increased soluble transferrin receptors. The study emphasizes the importance of identifying underlying causes for effective management.
This review highlighted the dysregulation of iron and iron-related proteins in alcohol consumers, noting variations in transferrin levels and other iron parameters. Researchers emphasized the need for a coherent overview of these alterations to aid in the diagnosis and management of alcohol-associated liver disease.
Research publications about Transferrin over time
9totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer